Dessirae Bennett
Nurse Practitioner · Wilmington, NCNPI 1225765118
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 392 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Teva Pharmaceuticals USA, Inc. at 29.5% of the total. Among nurse practitioner clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 392 payments — averaging $18.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Vanda Pharmaceuticals Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$834
- Otsuka America Pharmaceutical, Inc.$565
- Neurocrine Biosciences, Inc.$421
- Lundbeck LLC$249
- plus $2K from 16 others
What the payments were for
- Food & beverage$7,211100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 142 | $2,132 |
| Vanda Pharmaceuticals Inc. | 52 | $1,143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 46 | $834 |
| Otsuka America Pharmaceutical, Inc. | 22 | $565 |
| Neurocrine Biosciences, Inc. | 19 | $421 |
| Lundbeck LLC | 12 | $249 |
| AbbVie | 14 | $242 |
| Johnson & Johnson | 11 | $218 |
| Corium, LLC | 17 | $189 |
| Almatica Pharma LLC | 13 | $186 |
| Alkermes, Inc. | 7 | $174 |
| Axsome Therapeutics, Inc. | 9 | $174 |
| Novo Nordisk | 3 | $146 |
| Lilly USA, LLC | 2 | $137 |
| Idorsia Pharmaceuticals US Inc | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $80 |
| Bausch Health US, LLC | 5 | $79 |
| Validus Pharmaceuticals LLC | 1 | $48 |
| Neos Therapeutics, LP | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 1 | $33 |
| Tris Pharma Inc | 2 | $31 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,223 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 18 | $1,015 |
| Buspirone Hcl | 12 | $277 |
| Duloxetine Hcl | 15 | $192 |
| Trazodone Hcl | 12 | $127 |
| Alprazolam | 11 | $19 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Wilmington
- Bridgette WilliamsWilmington$35K
- Kelly GlissonWilmington$30K
- Lauren GardnerWilmington$28K
- Michelle StoughWilmington$24K
- Edith SaffoWilmington$19K
- Rebecca MaphisWilmington$18K
- Breanna BrousseauWilmington$12K
- Anna PaylorWilmington$11K
- Sandrivette JohnsonRaleigh$573K
- Ayeshia WrightMocksville$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.